Immuno-oncology DR5 as promising CAR T-cell target allowing inhibition of tumor cells and MDSCs March 11, 2026 No Comments University of Pennsylvania researchers investigated death receptor 5 (DR5 or CD262) as a chimeric antigen receptor (CAR) target for solid tumors.Read More
